HANNA KREMER: Open Payments
NPI 1649758871 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 76 payments from 15 companies in 2025. Trend: 2023 $1,455 · 2024 $760 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $474 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $158 |
| Madrigal Pharmaceuticals | 4 | $91 |
| PFIZER INC. | 4 | $76 |
| Gilead Sciences, Inc. | 4 | $70 |
| Celltrion USA Inc. | 4 | $67 |
| QOL Medical, LLC | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Ardelyx, Inc. | 2 | $37 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
Products named: RINVOQ, XIFAXAN, SKYRIZI, REZDIFFRA, VEGZELMA, Sucraid, VELSIPITY, CREON.
Industry payments across OH — which companies pay providers there.
